1. Home
  2. COOK vs PRME Comparison

COOK vs PRME Comparison

Compare COOK & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

N/A

Current Price

$1.04

Market Cap

184.8M

ML Signal

N/A

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

N/A

Current Price

$3.78

Market Cap

601.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COOK
PRME
Founded
1985
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.8M
601.1M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
COOK
PRME
Price
$1.04
$3.78
Analyst Decision
Hold
Buy
Analyst Count
7
5
Target Price
$2.04
$6.42
AVG Volume (30 Days)
860.5K
3.5M
Earning Date
11-05-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$582,799,000.00
$5,977,000.00
Revenue This Year
N/A
$111.80
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
647.13
52 Week Low
$0.71
$1.11
52 Week High
$3.08
$6.94

Technical Indicators

Market Signals
Indicator
COOK
PRME
Relative Strength Index (RSI) 57.33 44.72
Support Level $1.00 $3.95
Resistance Level $1.16 $4.42
Average True Range (ATR) 0.13 0.33
MACD 0.04 0.05
Stochastic Oscillator 76.10 42.67

Price Performance

Historical Comparison
COOK
PRME

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: